Results 181 to 190 of about 459,727 (225)
Some of the next articles are maybe not open access.
Meningococcal conjugate vaccines
Expert Opinion on Biological Therapy, 2005Disease caused by Neisseria meningitidis is associated with high mortality rates and significant sequelae. Polysaccharide meningococcal vaccines have been available for > 20 years, and have been used in travellers to control outbreaks, and in some countries for adolescents entering college, although they provide only a short duration of immunity and do
openaire +2 more sources
Meningococcal Vaccines and Vaccine Developments
2003Despite rapid advances in the diagnosis of bacterial infections and the availability of effective antibiotics, meningococcal disease continues to represent a substantial public health problem for most countries (1-4). Disease usually develops rapidly, is notoriously difficult to distinguish from other febrile illnesses, and generally has a high case ...
openaire +2 more sources
2003
The evaluation of meningococcal vaccines in humans is a challenging task. Issues of safety, and benefit to the individual patient and to the community may raise difficult ethical problems. The inherent variability of human responses, the rarity of clinical disease, age-dependence in the immune response, and the role of carriers complicates the ...
P, Farrington, E, Miller
openaire +2 more sources
The evaluation of meningococcal vaccines in humans is a challenging task. Issues of safety, and benefit to the individual patient and to the community may raise difficult ethical problems. The inherent variability of human responses, the rarity of clinical disease, age-dependence in the immune response, and the role of carriers complicates the ...
P, Farrington, E, Miller
openaire +2 more sources
Meningococcal vaccine in travelers
Current Opinion in Infectious Diseases, 2007New vaccines to prevent meningococcal disease have been licensed in recent years. It is therefore timely to discuss current vaccine strategies pertinent to international travelers in relation to the changing epidemiology.Serogroup W135 achieved epidemic status in Africa in 2002, and then largely disappeared over a short time period. The year 2006 saw a
openaire +2 more sources
Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers
New England Journal of Medicine, 2021Ray Borrow +2 more
exaly
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
New England Journal of Medicine, 2020Martin Maiden +2 more
exaly
Vaccination of Infants With Meningococcal Group B Vaccine (4CMenB) in England
New England Journal of Medicine, 2020Jay Lucidarme +2 more
exaly
Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children
New England Journal of Medicine, 2023An L D Boone +2 more
exaly
Meningococcal Disease and Vaccines
Pediatric Annals, 2001P, Dull, N, Rosenstein
openaire +2 more sources
Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia
New England Journal of Medicine, 2023Ed Clarke, Yuxiao Tang, Awa Traoré
exaly